Very proud to share our manuscript just published in @JCardioEP
The #ZAQscore is able to predict the presence and the extent of left atrial low voltage zones before #AFablation. Thanks to the Editorial Board and reviewers. @DrBradleyKnight#EPeeps
https://t.co/7ophEdImIW
Vascular closure devices (VCDs) for femoral venous haemostasis following catheter ablation of atrial fibrillation
In >28,000 patients, VCDs associated with ⬇️ vascular complications and bleeding events
Our latest in @JCardioEP
https://t.co/95SD9Id0vu
@DhirajGuptaBHRS#EPeeps
🥳We are excited to have the opportunity to dialogue with internationally renowned heart surgeon Prof. Michael A Borger- the Director of the University Clinic of Cardiac Surgery at the Leipzig Heart Center‼️
📢Do not miss this wonderful video👇
https://t.co/JMh8jkgSZN
Hot off the press 🔥: Over 50% of patients with PerAF in the U.S. undergo catheter ablation as a first-line rhythm-control therapy, and their outcomes are similar to those referred to ablation after failing class I/III AADs. https://t.co/MCFlQI7kbs
@JACCJournals@SteliosTzeis
We know that patients with AF recurrence after a single shot-PVI were female, older, had a larger left atrium compared to patients without AF recurrence.
These parameters are associated with the presence of low voltage areas and non-PV triggers
It may be that these patients could benefit from other ablation strategies that you cannot perform with single shot devices.
So it may be that one month after the first ablation we will have less recurrence of atrial fibrillation.
Are you planning to attend #EHRA2024 tomorrow (07.04.2024) in Berlin?
As we gear up for a day of enriching discussions and collaborations, I want to bring your attention to an event taking place nearby that might impact your travel plans.
Starting from 8:00 AM, a half marathon will take place near the congress venue. To ensure you are aware of any potential disruptions to your journey, I prepared a custom map outlining the marathon route and its proximity to the congress venue. Please take a moment to familiarize yourself with the map.
Due to the marathon, several streets will be closed starting from 7:00 AM. Alternative routes and transportation options may be necessary to ensure timely arrival at the congress.
Thanks, but that doesn't answer my question. I'll try to rephrase it:
The beauty of @drsuneet study is that it identifies also the predictors of long-term recurrent AF, regardless of whether the AF pattern is paroxysmal or persistent after a single shot-PVI.
Patients with AF recurrence were older, had a larger left atrial diameter and a higher CHA2DS2-VASc score (female population 33%) compared to patients without AF recurrence.
These parameters are associated with the presence of low voltage areas and non-PV triggers!
It may be that these patients could benefit from other ablation strategies that you cannot perform with single shot devices.
So it may be that one month after the ablation we will have less recurrence of atrial fibrillation.
What do you Think?
@natale_md@purerfellner@christophgelle1@LuigiDiBiaseMD@dogi84md
Thank you, the CIRCA-DOSE was focused on paroxysmal AF, in this study they analyzed both paroxysmal and persistent AF patients and identified predictors of long-term recurrent AF regardless of whether the AF pattern is paroxysmal or persistent.
In our previous study, we proposed an AF ablation workflow independent of AF pattern based on the same parameters. https://t.co/phhFtVaMa5
The blanking period (#BP) post Cryoballoon (#CB) Pulmonary Vein Isolation (#PVI) might be shorter than we think!
Continuous monitoring via #ILRs revealed that patients with AF recurrence and AF burden >0% after just 30 days Following #CB #PVI have a significantly higher risk of long-term recurrent AF regardless of whether the #AF pattern is #paroxysmal or #persistent. by @drsuneet
@heartablator Nice! And of course today we can offer more to our patients, low voltage zone-guided ablation, non-PVI triggers, LAA isolation, etc. ...
I think it doesn't make sense to just do PVI if you already know you're going to have a recurrence after 1 month.
Patients with an AF recurrence were older, had larger left atrial diameter, and had a higher CHA2DS2-VASc score (Female population 33%) in comparison to patients without AF recurrence.
👉https://t.co/iEKmiccqLA